Amundi
RGEN icon

Amundi’s Repligen RGEN Stock Holding History

Amundi’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
12,117
-32,842
-73% -$4.03M ﹤0.01% 1233
2026
Q1 		$5.3M Buy
44,959
+2,925
+7% +$409K ﹤0.01% 975
2025
Q4 		$6.89M Buy
42,034
+37,409
+809% +$5.86M ﹤0.01% 982
2025
Q3 		$694K Sell
4,625
-296
-6% -$36K ﹤0.01% 1241
2025
Q2 		$625K Sell
4,921
-80,376
-94% -$10.2M ﹤0.01% 1320
2025
Q1 		$10.4M Sell
85,297
-566
-0.7% -$87.1K ﹤0.01% 826
2024
Q4 		$13.3M Buy
85,863
+8,790
+11% +$1.26M ﹤0.01% 798
2024
Q3 		$10.4M Sell
77,073
-125,022
-62% -$17.9M ﹤0.01% 841
2024
Q2 		$24.4M Sell
202,095
-33,150
-14% -$5.2M 0.01% 668
2024
Q1 		$36.9M Sell
235,245
-131,907
-36% -$25.1M 0.02% 586
2023
Q4 		$63.6M Buy
367,152
+367
+0.1% +$57.1K 0.03% 484
2023
Q3 		$56M Buy
366,785
+43,840
+14% +$7.17M 0.03% 487
2023
Q2 		$45.9M Buy
322,945
+111,625
+53% +$17.9M 0.02% 527
2023
Q1 		$34.1M Buy
211,320
+20,848
+11% +$3.72M 0.02% 599
2022
Q4 		$33.8M Buy
190,472
+133,419
+234% +$24.2M 0.02% 583
2022
Q3 		$12.6M Buy
+57,053
New +$12M 0.01% 794
2022
Q2 		– Sell
-2,708
Closed -$490K – 1705
2022
Q1 		$490K Sell
2,708
-603
-18% -$115K ﹤0.01% 1295
2021
Q4 		$634K Hold
3,311
– – ﹤0.01% 1364
2021
Q3 		$957K Buy
3,311
+2,611
+373% +$670K ﹤0.01% 1297
2021
Q2 		$140K Buy
+700
New +$136K ﹤0.01% 1440

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Amundi's RGEN Position: Q2 2026 in Review

Amundi reduced its Repligen (RGEN) stake by 73% in Q2 2026, selling an estimated $4.03M and leaving 12,117 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Amundi first reported a position in RGEN in Q2 2021 and has held it in 20 quarters since. The position peaked at $63.6M in Q4 2023. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Amundi held 12,117 shares of Repligen worth $1.65M as of Q2 2026.
  • Amundi sold 32,842 Repligen shares in Q2 2026, an estimated $4.03M.
  • Repligen made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1233 holding.
  • Amundi first reported a position in Repligen in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Repligen position peaked at $63.6M in Q4 2023.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.